Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
Bajor M, Graczyk-Jarzynka A, Marhelava K, Burdzinska A, Muchowicz A, Goral A, Zhylko A, Soroczynska K, Retecki K, Krawczyk M, Klopotowska M, Pilch Z, Paczek L, Malmberg KJ, Wälchli S, Winiarska M, Zagozdzon R. Bajor M, et al. Among authors: walchli s. J Immunother Cancer. 2022 Jan;10(1):e002500. doi: 10.1136/jitc-2021-002500. J Immunother Cancer. 2022. PMID: 35078921 Free PMC article.
Human c-SRC kinase (CSK) overexpression makes T cells dummy.
Inderberg EM, Mensali N, Oksvold MP, Fallang LE, Fåne A, Skorstad G, Stenvik GE, Progida C, Bakke O, Kvalheim G, Myklebust JH, Wälchli S. Inderberg EM, et al. Among authors: walchli s. Cancer Immunol Immunother. 2018 Apr;67(4):525-536. doi: 10.1007/s00262-017-2105-9. Epub 2017 Dec 16. Cancer Immunol Immunother. 2018. PMID: 29248956 Free PMC article.
Treating osteosarcoma with CAR T cells.
Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S. Köksal H, et al. Among authors: walchli s. Scand J Immunol. 2019 Mar;89(3):e12741. doi: 10.1111/sji.12741. Epub 2019 Jan 15. Scand J Immunol. 2019. PMID: 30549299 Free article. Review.
A Spheroid Killing Assay by CAR T Cells.
Dillard P, Köksal H, Inderberg EM, Wälchli S. Dillard P, et al. Among authors: walchli s. J Vis Exp. 2018 Dec 12;(142). doi: 10.3791/58785. J Vis Exp. 2018. PMID: 30596389
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma.
Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH. Josefsson SE, et al. Among authors: walchli s. Cancer Immunol Res. 2019 Mar;7(3):355-362. doi: 10.1158/2326-6066.CIR-18-0351. Epub 2019 Jan 18. Cancer Immunol Res. 2019. PMID: 30659053 Free PMC article.
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.
Köksal H, Dillard P, Josefsson SE, Maggadottir SM, Pollmann S, Fåne A, Blaker YN, Beiske K, Huse K, Kolstad A, Holte H, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S. Köksal H, et al. Among authors: walchli s. Blood Adv. 2019 Apr 23;3(8):1230-1243. doi: 10.1182/bloodadvances.2018029678. Blood Adv. 2019. PMID: 30979721 Free PMC article.
Long-term surviving cancer patients as a source of therapeutic TCR.
Inderberg EM, Wälchli S. Inderberg EM, et al. Among authors: walchli s. Cancer Immunol Immunother. 2020 May;69(5):859-865. doi: 10.1007/s00262-019-02468-9. Epub 2020 Jan 8. Cancer Immunol Immunother. 2020. PMID: 31915853 Free PMC article. Review.
Colorectal cysts as a validating tool for CAR therapy.
Dillard P, Lie M, Baken E, Lobert VH, Benard E, Köksal H, Inderberg EM, Wälchli S. Dillard P, et al. Among authors: walchli s. BMC Biotechnol. 2020 Jun 1;20(1):30. doi: 10.1186/s12896-020-00623-0. BMC Biotechnol. 2020. PMID: 32487146 Free PMC article.
96 results